Case Study: Rebranding & Scaling Elevaris Medical Devices

Transforming a Global MedTech Brand

When Spectra Medical and XL Precision Technologies merged to form Elevaris Medical Devices, the new company needed more than a fresh name and logo. They required a global brand identity, a modernized digital ecosystem, and a lead generation engine capable of reaching decision-makers across pharma, medtech, and biotech.

Bluebirds Marketing partnered with Elevaris to bring this vision to life.

The
Challenge

Unite two legacy companies under one cohesive, trusted global brand.

Generate qualified leads in competitive markets like pharma, medtech, and biotech.

Modernize digital channels — website, CRM, social — for measurable business impact.

Our
Approach

We built a strategy rooted in the PESO model (Paid, Earned, Shared, Owned) to ensure every channel worked together.

1. Rebrand & Launch

  • Global “Brand Day” rollout in the U.S., U.K., and South Korea.

  • New collateral, trade show activations, and international media coverage.

2. Digital Transformation

  • Website and e-commerce redesign with HubSpot CRM integration.

  • SEO optimization and a mobile-first, user-driven design.

3. Content & Thought Leadership

  • Brochures, white papers, case studies, and executive webinars.

  • 500+ new images and video assets for global consistency.

4. Lead Generation
Campaign (NRE)

  • Year-long initiative targeting OEMs, startups, and R&D teams.

  • Content syndication, webinars, and conference sponsorships.

5. Social Media Strategy

  • Consolidated LinkedIn presence with streams for brand awareness, lead gen, thought leadership, and culture/recruitment.

The
Results

Digital Engagement

  • 25,000 new users and 10,000 pageviews within weeks of relaunch.

  • Average time on page: 103 seconds, with user journeys guided by clear CTAs.

Lead Generation

  • First MD&O syndication delivered 100 guaranteed leads.

  • 19 qualified leads in week one, including global leaders.

  • 3-month campaign resulted in 800+ leads.

Media & Visibility

  • Featured in leading industry outlets: MPO, ODT, MD&O, and MD&DI.

  • Executive thought leadership showcased across earned, paid, and shared channels.

Email & Social Performance

  • Email CTRs 2% above industry average.

  • Growing LinkedIn engagement among target decision-makers and investors.

What’s
Next

Elevaris and Bluebirds continue to build momentum by:

  • Scaling campaigns with gated assets and additional placements.

  • Expanding earned media opportunities in specialty clinical markets.

  • Optimizing the new website and CRM workflows for higher conversions.

  • Deploying multimedia content to fuel thought leadership and brand recall.

The
Bluebirds
Impact

By aligning brand transformation, digital modernization, and lead generation under one integrated plan, Bluebirds helped Elevaris establish itself as a global CDMO leader—positioned for long-term growth and industry visibility.

Want results like this?

Let's Talk